SELLAS Life Sciences Group Inc (FRA:RXK3)
€ 11.65 +0.55 (+4.95%) Market Cap: 2.21 Bil Enterprise Value: 2.12 Bil PE Ratio: 0 PB Ratio: 21.60 GF Score: 25/100